Health Care: Drugs

Chembio Diagnostics Inc (CEMI: NASDAQ)

$5.325 n/a | n/a%
11/24/15 - 03:52 PM ET
Company Profile
Price and Volume
Recent Price 5.33
52 Week High 5.53
52 Week Low 3.33
Avg. Daily Vol. (Mil) 0.02
Beta (3 year) 1.24
Share Related Items
Mkt Cap (Mil) 51.27
Shares Out (Mil) 9.63
Float (Mil) 8.23
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.30
Current Ratio 3.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.90
Price/Book 2.81
Price/Cash Flow -48.40
Per Share Data
Earnings -0.23
Sales 2.80
Book Value 1.89
Cash Flow -0.11
Business Summary
Chembio Diagnostics Inc develops, manufacture market & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.
General Information
3661 Horseblock Road
Medford, NY 11763
Industry : Drugs
Sector: Health Care
Employees: 166
CEO: Mr. John J. Sperzel, III
Short Interest
Current Month (Mil) 0.02
Previous Month (Mil) 0.03
Short Interest Ratio (Days) 0.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -9.80
Return on Investments -12.30
Gross Margin 47.20
EBIT Margin -11.20
Profit Margin -8.30

Portfolios with CEMI

Latest CEMI Headlines from TheStreet

More Financial News for CEMI

Press Releases for CEMI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter